California-based Allez Health, formerly known as Zense-Life, has secured $60 million in Series A+ financing led by Osang Healthcare. The company focuses on continuous glucose monitoring biosensors to analyze health data and improve patient performance. The funding will support operations, regulatory approval filings, manufacturing, and clinical trials. The leadership team consists of former Dexcom leaders, with a CEO, CTO, and CSO bringing expertise from the development of Dexcom’s G4 CGM. Allez Health aims to provide affordable and reliable health solutions. In the market, Dexcom’s Stelo received FDA clearance for over-the-counter use, while Kakao Healthcare introduced the AI-enabled PASTA app for diabetes management.
Source link
Biosensor technology company Allez Health secures $60M
